SEC Filings
Filing date | Form | Description | View |
---|---|---|---|
S-3/A | Pre-effective amendment to an S-3 filing |
View HTML | |
DEF 14A | Official notification to shareholders of matters to be brought to a vote ("Proxy") |
View HTML | |
DEF 14A | Official notification to shareholders of matters to be brought to a vote ("Proxy") |
View HTML | |
DEF 14A | Official notification to shareholders of matters to be brought to a vote ("Proxy") |
View HTML | |
DEF 14A | Official notification to shareholders of matters to be brought to a vote ("Proxy") |
View HTML | |
DEF 14A | Official notification to shareholders of matters to be brought to a vote ("Proxy") |
View HTML | |
DEF 14A | Official notification to shareholders of matters to be brought to a vote ("Proxy") |
View HTML | |
DEF 14A | Official notification to shareholders of matters to be brought to a vote ("Proxy") |
View HTML | |
DEF 14A | Official notification to shareholders of matters to be brought to a vote ("Proxy") |
View HTML | |
DEF 14A | Official notification to shareholders of matters to be brought to a vote ("Proxy") |
View HTML EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA |
Data provided by Kaleidoscope.
For SEC filings prior to June 2, 2014, the date of the spin-off of Theravance Biopharma, Inc. from Theravance, Inc., please visit Innoviva, Inc.